drugset / Trial / NCT02120677

Topical Itraconazole in the Treatment of Basal Cell Carcinoma

NCT02120677

Phase 0 Completed 5 enrolled Johns Hopkins University
NaSingle-groupOpen-labelTreatment

Summary

This research is being done to study the molecular effects of topically applied itraconazole ointment on the growth of basal cell carcinomas.

Timeline

Start
2014-05
Primary completion
2019-01-30
Completion
2019-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 50 % Topical

Indications